A predictive value of CA-125 elimination of rate constant K(KELIM) on prognosis and duration of bevacizumab maintenance therapy in first platinum-sensitive recurrence of ovarian cancer

被引：0
|
作者：
Hwang, Dong Won [1 ]
Park, Soo Jin [1 ]
Kim, Hee Seung [1 ]
机构：
[1] Seoul Natl Univ Hosp, Obstet & Gynecol, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷 / SUPPL_4期
关键词：
D O I：
10.1136/ijgc-2023-IGCS.322
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP248
引用
收藏
页码：A179 / A180
页数：2
相关论文
共 43 条
  • [1] Preoperative CA-125 Value as a Predictive Factor for Postoperative Outcome in First Relapse of Platinum-sensitive Serous Ovarian Cancer
    Parashkevova, Asya
    Sehouli, Jalid
    Richter, Rolf
    Dimitrova, Desislava
    Braicu, Elena Ioana
    Muallem, Mustafa Zelal
    ANTICANCER RESEARCH, 2018, 38 (08) : 4865 - 4870
  • [2] OPTIMAL CYTOREDUCTION AND PLATINUM-FREE INTERVAL AFFECTING THE DURATION OF BEVACIZUMAB-BASED MAINTENANCE THERAPY AND PROGNOSIS IN THE FIRST PLATINUM-SENSITIVE RECURRENCE OF OVARIAN CANCER
    Oh, Soohyun
    Park, Soo Jin
    Park, Min Young
    Kim, Jae-Weon
    Park, Noh Hyun
    Lee, Seungho
    Kim, Hee Seung
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A163 - A165
  • [3] The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer: A Narrative Review
    Lauby, Ambroise
    Colomban, Olivier
    Corbaux, Pauline
    Peron, Julien
    Van Wagensveld, Lilian
    Gertych, Witold
    Bakrin, Naoual
    Descargues, Pierre
    Lopez, Jonathan
    Kepenekian, Vahan
    Glehen, Olivier
    Philip, Charles Andre
    Devouassoux-Shisheboran, Mojgan
    Tod, Michel
    Freyer, Gilles
    You, Benoit
    CANCERS, 2022, 14 (01)
  • [4] Clinical impact of CA-125 ELIMination rate constant K (KELIM) on surgical strategy in advanced serous ovarian cancer patients
    Bouvarel, Barnabe
    Colomban, Oliver
    Frenel, Jean-Sebastien
    Loaec, Cecile
    Bourgin, Charlotte
    Berton, Dominique
    Freyer, Gilles
    You, Benoit
    Classe, Jean-Marc
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (04) : 574 - 580
  • [5] Prognostic and predictive significance of CA-125 elimination rate constant K (KELIM) in ovarian cancer patients treated with neoadjuvant chemotherapy in a real-world setting.
    Liontos, Michael
    Papatheodoridi, Alkistis
    Kunadis, Elena
    Svarna, Anna
    Theofanakis, Charalampos
    Fiste, Oraianthi
    Rouvali, Angeliki
    Goula, Kalliroi
    Markellos, Christos
    Andrikopoulou, Angeliki
    Potiri, Eirini
    Papanota, Aristea-Maria
    Kaparelou, Maria
    Koutsoukos, Konstantinos
    Thomakos, Nikolaos
    Haidopoulos, Dimitrios
    Rodolakis, Alexandros
    Zagouri, Flora
    You, Benoit
    Dimopoulos, Meletios A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial
    You, Benoit
    Robelin, Patrick
    Tod, Michel
    Louvet, Christophe
    Lotz, Jean-Pierre
    Abadie-Lacourtoisie, Sophie
    Fabbro, Michel
    Desauw, Christophe
    Bonichon-Lamichhane, Nathalie
    Kurtz, Jean-Emmanuel
    Follana, Philippe
    Leheurteur, Marianne
    Del Piano, Francesco
    Ferron, Gwenael
    De Rauglaudre, Gaetan
    Ray-Coquard, Isabelle
    Combe, Pierre
    Chevalier-Place, Annick
    Joly, Florence
    Leary, Alexandra
    Pujade-Lauraine, Eric
    Freyer, Gilles
    Colomban, Olivier
    CLINICAL CANCER RESEARCH, 2020, 26 (17) : 4625 - 4632
  • [7] The modeled CA-125 elimination rate constant k (KELIM) score as a predictor of treatment response in patients with advanced high grade serous ovarian cancer
    Piedimonte, Sabrina
    Kim, Soyoun Rachel
    Clark, Mitchell
    Lheureux, Stephanie
    May, Taymaa
    Bernardini, Marcus
    Atenafu, Eshetu
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S109 - S109
  • [8] Prognostic Role of CA-125 Elimination Rate Constant (KELIM) in Patients with Advanced Epithelial Ovarian Cancer Who Received PARP Inhibitors
    Kim, Ji Hyun
    Kim, Eun Taeg
    Kim, Se Ik
    Park, Eun Young
    Park, Min Young
    Park, Sang-Yoon
    Lim, Myong Cheol
    CANCERS, 2024, 16 (13)
  • [9] Serum CA125 level as predictors of the efficacy of olaparib maintenance therapy for platinum-sensitive relapsed ovarian cancer
    Asano, Fumio
    Momomura, Mai
    Morisada, Tohru
    Tsushima, Kana
    Haruna, Yumi
    Shibuya, Hiromi
    Matsumoto, Hironori
    Kobayashi, Yoichi
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2023, 49 (12) : 2883 - 2888
  • [10] Platinum-free Interval May Predict Duration of Maintenance Bevacizumab and Survival in Platinum-sensitive Recurrent Ovarian Cancer
    Oh, Soo hyun
    Park, Soo jin
    Lee, Seungmee
    Lee, Seungho
    Kim, Hee seung
    IN VIVO, 2024, 38 (01): : 467 - 473
12345